Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?The Motley Fool • 09/07/26
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly StockThe Motley Fool • 09/06/26
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 YearsThe Motley Fool • 09/05/26
Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does.The Motley Fool • 09/05/26
Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.Market Watch • 09/05/26
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/04/26
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?Zacks Investment Research • 09/02/26
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B DealZacks Investment Research • 09/01/26
Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet24/7 Wall Street • 09/01/26